New Insights Into the Prognostic Value of Ki-67 Labeling Index in Patients With Triple-Negative Breast Cancer

Oncotarget - United States
doi 10.18632/oncotarget.8531
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index

Clinical Breast Cancer
Cancer ResearchOncology
2017English

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Prognostic Importance of Ki-67 Labeling Index in Grade II Glial Tumors

Turk Onkoloji Dergisi
Oncology
2018English

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Prognostic Role of Family History in Patients With Triple Negative Breast Cancer

Turk Onkoloji Dergisi
Oncology
2020English

IDH1/2 Mutation Status Combined With Ki-67 Labeling Index Defines Distinct Prognostic Groups in Glioma

Oncotarget
Oncology
2015English

Identification of New Prognostic Biomarkers for Triple Negative Breast Cancer

English

Prognostic Value of Kallikrein-Related Peptidase 12 (KLK12) mRNA Expression in Triple-Negative Breast Cancer Patients

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy